You have 9 free searches left this month | for more free features.

sunitinib

Showing 1 - 25 of 196

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastrointestinal Stromal Tumors Trial in Miami (Sunitinib, Regorafenib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Miami, Florida
    University of Miami
Jan 3, 2023

go Back Into Records and Observe How People With Metastatic

Not yet recruiting
  • Carcinoma, Renal Cell
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Sunitinib
  • Istanbul, Turkey
    Pfizer
Feb 15, 2023

Metastatic and/or Advanced Renal Cell Carcinoma, Treated With

Completed
  • Carcinoma
  • Renal Cell
  • London, United Kingdom
    Pfizer UK
Jan 9, 2023

GIST Trial (Ripretinib, Sunitinib)

Not yet recruiting
  • GIST
  • (no location specified)
Feb 8, 2023

Brain Metastases Trial in Toronto (Sunitinib)

Completed
  • Brain Metastases
  • Sunitinib
  • Toronto, Ontario, Canada
    University Health Network, Princess Margaret Hospital
Oct 6, 2022

Renal Cell Carcinoma Trial in Houston (Sunitinib, Nephrectomy)

Active, not recruiting
  • Renal Cell Carcinoma
  • Sunitinib
  • Nephrectomy
  • Houston, Texas
  • +1 more
Oct 11, 2022

Advanced Gastrointestinal Stromal Tumors, Metastatic Cancer Trial in United States (CGT9486 plus sunitinib, CGT9486, Sunitinib)

Recruiting
  • Advanced Gastrointestinal Stromal Tumors
  • Metastatic Cancer
  • CGT9486 plus sunitinib
  • +2 more
  • Duarte, California
  • +11 more
Aug 10, 2022

Thymoma, Thymus Tumors Trial run by the NCI (Sunitinib)

Active, not recruiting
  • Thymoma
  • Thymus Neoplasms
  • Sunitinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 17, 2022

Metastatic Renal Cell Carcinoma Trial in Lebanon, Burlington (Sunitinib, Temsirolimus)

Active, not recruiting
  • Metastatic Renal Cell Carcinoma
  • Lebanon, New Hampshire
  • +1 more
Aug 9, 2022

Refractory Solid Tumors Trial in Seoul (Sunitinib)

Completed
  • Refractory Solid Tumors
  • Sunitinib
  • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Renal Cell Carcinoma, Ovarian Carcinoma, Thyroid Carcinoma Trial in Groningen (Olaparib, Lenvatinib, Sunitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Groningen, Netherlands
    University Medical Center Groningen
Jul 13, 2023

Renal Cell Carcinoma Trial (Pembrolizumab, Axitinib, Sunitinib)

Active, not recruiting
  • Renal Cell Carcinoma
  • Pembrolizumab
  • +2 more
  • (no location specified)
Aug 17, 2022

Real-world Clinical Patterns Of Care And Outcomes Among AfME

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Sunitinib
  • Algers, Algeria
  • +5 more
Aug 16, 2022

Refractory Solid Tumors Trial in Seoul (sunitinib)

Completed
  • Refractory Solid Tumors
  • sunitinib
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

Recruiting
  • Neoplasms
  • +12 more
  • Nanjing, Jiangsu, China
    Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023

Gliosarcoma, CNS Sarcoma Trial run by the NCI (Sunitinib, wGT3x-BT)

Terminated
  • Gliosarcoma
  • Central Nervous System Sarcoma
  • Sunitinib
  • wGT3x-BT
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 24, 2022

Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 6, 2022

Clear-cell Renal Cell Carcinoma, RCC, Kidney Cancer Trial in Birmingham (Avelumab, Sunitinib)

Withdrawn
  • Clear-cell Renal Cell Carcinoma
  • +3 more
  • Birmingham, Alabama
    University of Alabama Hematology Oncology Clinic at Medical West
Feb 14, 2022

Renal Cell Carcinoma, Metastatic Trial in Worldwide (Intuvax (INN: ilixadencel), Sunitinib)

Completed
  • Renal Cell Carcinoma, Metastatic
  • Intuvax (INN: ilixadencel)
  • Sunitinib
  • Chicago, Illinois
  • +27 more
Jul 23, 2022

Paraganglioma, Pheochromocytoma Trial in Canada, Netherlands (Sunitinib)

Active, not recruiting
  • Paraganglioma
  • Pheochromocytoma
  • Sunitinib
  • Calgary, Alberta, Canada
  • +3 more
Nov 29, 2021

Renal Cell Carcinoma Metastatic Trial in Hershey (Abemaciclib, Sunitinib)

Active, not recruiting
  • Renal Cell Carcinoma Metastatic
  • Hershey, Pennsylvania
    Penn State Cancer Institute
Jan 5, 2022

Kidney Tumors, Metastatic Renal Cell Cancer Trial in Besancon (Sunitinib)

Active, not recruiting
  • Kidney Neoplasms
  • Metastatic Renal Cell Cancer
  • Sunitinib
  • Besancon, Franche-ComtĂ©, France
    CHU Besancon
Nov 17, 2021

CR With Sunitinib Treatment In mRCC Patients

Completed
  • Complete Remission in Renal Cell Carcinoma
  • sunitinib
  • Marseille, Cedex 5, France
  • +13 more
Feb 14, 2022

Renal Cell Carcinoma Trial (Sunitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • Sunitinib
  • (no location specified)
Sep 11, 2023

Non GIST Sarcomas Trial in France (sunitinib)

Completed
  • Non GIST Sarcomas
  • sunitinib
  • Bordeaux, France
  • +5 more
Jan 3, 2022